Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic in breast cancer surgery
NCT06174363Recruiting
- Sponsor
- Yonsei University
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acetaminophen + ibuprofen in postoperative pain, sponsored by Yonsei University. Primary endpoint: Analgesic effect of Maxigesic at 48 hours. Started Dec 2023; status: recruiting.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06174363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06174363.